Beone Medicines Ltd Stock Performance
as on December 3, 2025 at 2:29 am IST
Day's Low
Day's High
$328.79$338.59
0.41%
Downside
2.56%
Upside
52 Week's Low
52 Week's High
$172.67$385.2247.70%
Downside
16.68%
Upside
Beone Medicines Ltd share price movements today
- Previous Close
- $335.60
- Open
- $334.99
- Volume
- 198.2K
- Day's Low - High
- $328.79 - $338.59
- 52 Week Low - High
- $172.67 - $385.22
Beone Medicines Ltd Historical Returns
- 1 Month Return
- + 5.88 %
- 3 Month Return
- -1.81 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Beone Medicines Ltd Stock Fundamentals & Key Indicators
Check Beone Medicines Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$37.1B
EPS (TTM)
3.4033
Dividend Yield
0.00%
PE Ratio (TTM)
671.2
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
1.81%
Beone Medicines Ltd Stock Valuation
Track how Beone Medicines Ltd P/E has moved over time to understand its valuation trends.
Beone Medicines Ltd in the last 5 years
Lowest (-141.76x)
June 30, 2025
Industry (0.00x)
December 3, 2025
Today (671.20x)
December 3, 2025
Highest (-62.85x)
March 31, 2025
Today’s Price to Earnings Ratio: 671.20x
Beone Medicines Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Beone Medicines Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $37.1B | NA | 671.2 | 1.38% | |
| BUY | $44.1B | 422.91% | -16.34 | -264.83% | |
| BUY | $60.1B | 254.45% | 1420.5 | 1.36% | |
| BUY | $109.1B | 90.92% | 29.93 | 31.35% | |
| BUY | $79.5B | 48.75% | 17.98 | 32.13% |
Beone Medicines Ltd Stock’s Investor Sentiment and Interest
Search interest for Beone Medicines Ltd Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Beone Medicines Ltd Quarterly Profit & Loss
All numbers in Millions USD
Beone Medicines Ltd Annual Profit & Loss
All numbers in Millions USD
Beone Medicines Ltd Quarterly Cash Flow
All numbers in Millions USD
Beone Medicines Ltd Annual Cash Flow
All numbers in Millions USD
Insights on Beone Medicines Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Beone Medicines Ltd has shown impressive profit growth over the last four quarters. The net profit rose from -151.88 million dollars to 124.84 million dollars. This represents an average increase of 4060.8% each quarter, indicating a strong positive trend in the company's financial performance.
- POSITIVE IMPACT
Revenue Rich
Beone Medicines Ltd has shown a positive trend in revenue over the last three quarters. The company's revenue increased from $1.11 billion to $1.41 billion, reflecting an average growth of 11.0% per quarter.
- POSITIVE IMPACT
Price Rise
In the last 1 year, ONC stock has moved up by 60.3%
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 914.2% return, outperforming this stock by 850.6%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 185.2% return, outperforming this stock by 124.9%
About Beone Medicines Ltd
| Organisation | Beone Medicines Ltd |
| Headquarters | Aeschengraben 27, Basel, Switzerland, 4051 |
| CEO | Mr. John V. Oyler |
| E-voting on shares | Click here to vote |
Key Management of Beone Medicines Ltd
Name | Title |
|---|---|
Mr. Marcello Damiani | Chief Technology Officer |
Mr. John V. Oyler | Co-Founder, Executive Chairman & CEO |
Dr. Xiaodong Wang Ph.D. | Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder |
Mr. Chan Lee | General Counsel & Senior VP |
Mr. Wang Lai Ph.D. | Global Head of Research & Development |
Mr. Titus B. Ball | VP & Chief Accounting Officer |
Dr. Xiaobin Wu Ph.D. | President, COO & GM of China |
Mr. Aaron Rosenberg | Chief Financial Officer |
Ms. Liza Heapes | Head of Investor Relations |
Ms. Eleanor Duff Ph.D. | Senior VP & Head of Corporate Communications |
FAQs
What is Beone Medicines Ltd share price today?
Beone Medicines Ltd share price today is $330.14 as on at the close of the market. Beone Medicines Ltd share today touched a day high of $338.59 and a low of $328.79.
What is the 52 week high and 52 week low for Beone Medicines Ltd share?
Beone Medicines Ltd share touched a 52 week high of $385.22 on and a 52 week low of $172.67 on . Beone Medicines Ltd stock price today i.e. is closed at $330.14,which is 14.30% down from its 52 week high and 91.20% up from its 52 week low.
What is Beone Medicines Ltd's market capitalisation today?
Beone Medicines Ltd market capitalisation is $0.04T as on .
How to invest in Beone Medicines Ltd Stock (ONC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Beone Medicines Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beone Medicines Ltd Shares that will get you 0.0045 shares as per Beone Medicines Ltd share price of $330.14 per share as on December 3, 2025 at 2:29 am IST.
What is the minimum amount required to buy Beone Medicines Ltd Stock (ONC) from India?
Indian investors can start investing in Beone Medicines Ltd (ONC) shares with as little as ₹89.935 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.35 in Beone Medicines Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Beone Medicines Ltd share’s latest price of $330.14 as on December 3, 2025 at 2:29 am IST, you will get 0.0303 shares of Beone Medicines Ltd. Learn more about
fractional shares .